Karen H. Lu, MD, on Next Steps in Evaluating Genetic Testing in Underrepresented Minorities
The MD Anderson Cancer Center expert discussed further research in delivering online accessible genetic testing.
There may still be a disconnect in women who are at risk for ovarian cancer to actually receive genetic testing, according to Karen H. Lu, MD.
At the 2020 ASCO Virtual Scientific Program, Lu – from the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center – presented on findings from the MAGENTA trial, designed to test whether pre and/or post-test genetic counseling is needed to optimally deliver online accessible genetic testing.
She spoke with CancerNetwork about next steps in this area of research.
Transcription:
One area that we that was really highlighted was we had wanted because the goal was to make this testing more accessible. We had really hoped to have a high minority population in rural population. And it turned out that that we did not fulfill that goal. And so I think a follow up would be to really focus on underrepresented minority populations and rural populations and focus to see if this form is helpful to that to those groups.
